ストックスクリーナーアプリを入手
1.36
2.26%
0.03
アフターアワーズ：
1.37
0.01
+0.74%
前日終値:
$1.33
開ける：
$1.36
24時間の取引高:
815.02K
Relative Volume:
0.50
時価総額：
$80.93M
収益：
-
当期純損益:
$-144.01M
株価収益率:
-0.3392
EPS:
-4.01
ネットキャッシュフロー:
$-113.02M
1週間 パフォーマンス:
-6.85%
1か月 パフォーマンス:
-32.67%
6か月 パフォーマンス:
-35.24%
1年 パフォーマンス:
-85.49%
1日の値動き範囲:
$1.31
$1.38
1週間の範囲:
$1.31
$1.50
52週間の値動き範囲:
$1.2905
$9.6664
Biomea Fusion Inc Stock (BMEA) Company Profile
BMEA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.36 | 94.04M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-28 | 開始されました | Jefferies | Buy |
| 2025-06-03 | 再開されました | Piper Sandler | Overweight |
| 2024-10-09 | 開始されました | Edward Jones | Buy |
| 2024-09-27 | アップグレード | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | アップグレード | Truist | Hold → Buy |
| 2024-08-29 | 開始されました | CapitalOne | Overweight |
| 2024-06-11 | ダウングレード | Truist | Buy → Hold |
| 2024-06-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-04-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-06 | 開始されました | Truist | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-12 | 開始されました | Barclays | Overweight |
| 2023-03-29 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-02-24 | 開始されました | Citigroup | Buy |
| 2022-06-02 | 再開されました | H.C. Wainwright | Buy |
| 2022-01-12 | 開始されました | H.C. Wainwright | Buy |
| 2021-12-17 | 開始されました | Oppenheimer | Outperform |
| 2021-05-11 | 開始されました | JP Morgan | Overweight |
| 2021-05-11 | 開始されました | Jefferies | Buy |
| 2021-05-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Biomea Fusion Inc (BMEA) 最新ニュース
Is Biomea Fusion Inc. a candidate for recovery playMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Is Biomea Fusion Inc. trending in predictive chart modelsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Biomea Fusion Inc.’s volatility index tracking explained2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Long term hold vs stop loss in Biomea Fusion Inc.2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Real time pattern detection on Biomea Fusion Inc. stock2025 EndofYear Setup & Weekly Market Pulse Alerts - newser.com
Can Biomea Fusion Inc. stock rebound after recent weakness2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Is Biomea Fusion Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Swing Trade Setup Alerts - newser.com
Strategies to average down on Biomea Fusion Inc.Weekly Earnings Recap & Verified Short-Term Plans - newser.com
Biomea Fusion’s BMF-650: A New Hope in Obesity Treatment? - TipRanks
Can trapped investors hope for a rebound in Biomea Fusion Inc.Trade Volume Report & Consistent Return Strategy Ideas - newser.com
How risky is Biomea Fusion Inc. stock now2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Why Biomea Fusion Inc. stock could be next big winnerWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Biomea Fusion’s BMF-219 Trial for Type 1 Diabetes: A Terminated Phase 2 Study - TipRanks
Can Biomea Fusion Inc. stock hit analyst price targetsTrade Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Is Biomea Fusion Inc. stock dividend yield sustainable2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Cormorant Asset Management, LP Reduces Stake in Biomea Fusion Inc - GuruFocus
Biomea Fusion stock hits 52-week low at $3.58 amid sharp decline - MSN
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025 - Investing News Network
Biomea Fusion, Inc. to Present Preclinical Data for BMF-650 and Icovamenib at ObesityWeek® 2025 - Quiver Quantitative
Biomea (Nasdaq: BMEA) to present ObesityWeek posters on BMF-650 and icovamenib/semaglutide - Stock Titan
Is Biomea Fusion Inc. stock bottoming outMarket Activity Summary & Capital Protection Trade Alerts - newser.com
Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Will Biomea Fusion Inc. stock gain from strong economyQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - fcp.pa.gov.br
Biomea Fusion doses first patient in oral GLP-1 obesity drug trial - Investing.com Philippines
Biomea Fusion Inc (BMEA) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):